CorMedix's DefenCath sales and Melinta deal raise growth stakes while Puma Biotechnology's Nerlynx-led breast cancer franchise aids growth.

With office parties, cocktails with friends and end-of-year celebrations in full swing, many of us brace for hangovers without realising that festive drinking can have a real and often overlooked ...